Richard Bergstrom

604 total citations
16 papers, 460 citations indexed

About

Richard Bergstrom is a scholar working on Psychiatry and Mental health, Pharmacology and Surgery. According to data from OpenAlex, Richard Bergstrom has authored 16 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 4 papers in Pharmacology and 3 papers in Surgery. Recurrent topics in Richard Bergstrom's work include Schizophrenia research and treatment (5 papers), Treatment of Major Depression (4 papers) and Bipolar Disorder and Treatment (3 papers). Richard Bergstrom is often cited by papers focused on Schizophrenia research and treatment (5 papers), Treatment of Major Depression (4 papers) and Bipolar Disorder and Treatment (3 papers). Richard Bergstrom collaborates with scholars based in United States, Sweden and Russia. Richard Bergstrom's co-authors include Jill Chappell, Mary Pat Knadler, Evelyn D. Lobo, Kjell Tullus, Kelm Hjälmås, Alvin I. Goodman, Richard Solomon, Michael Blumenfield, E. Knoesel and Charles M. Beasley and has published in prestigious journals such as The Lancet, Diabetes Care and The British Journal of Psychiatry.

In The Last Decade

Richard Bergstrom

15 papers receiving 436 citations

Peers

Richard Bergstrom
Cynthia J. Harris United States
B Astruc France
Ersin Yariş Türkiye
Robert M. Wallis United Kingdom
M. J. WATSON United Kingdom
Paul Williams United States
A. Cournot France
Allen Mj United Kingdom
Kim Tang United Kingdom
Kevin F Foley United States
Cynthia J. Harris United States
Richard Bergstrom
Citations per year, relative to Richard Bergstrom Richard Bergstrom (= 1×) peers Cynthia J. Harris

Countries citing papers authored by Richard Bergstrom

Since Specialization
Citations

This map shows the geographic impact of Richard Bergstrom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Bergstrom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Bergstrom more than expected).

Fields of papers citing papers by Richard Bergstrom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Bergstrom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Bergstrom. The network helps show where Richard Bergstrom may publish in the future.

Co-authorship network of co-authors of Richard Bergstrom

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Bergstrom. A scholar is included among the top collaborators of Richard Bergstrom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Bergstrom. Richard Bergstrom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Mitchell, Malcolm I., Prajakti A. Kothare, Richard Bergstrom, et al.. (2013). Single- and Multiple-Dose Pharmacokinetic, Safety, and Tolerability Profiles of Olanzapine Long-Acting Injection: An Open-Label, Multicenter, Nonrandomized Study in Patients With Schizophrenia. Clinical Therapeutics. 35(12). 1890–1908. 20 indexed citations
2.
Knadler, Mary Pat, Evelyn D. Lobo, Jill Chappell, & Richard Bergstrom. (2011). Duloxetine. Clinical Pharmacokinetics. 50(5). 281–294. 179 indexed citations
3.
Tohen, Mauricio, Charles L. Bowden, Smulevich Ab, et al.. (2008). Olanzapine plus carbamazepinev.carbamazepine alone in treating manic episodes. The British Journal of Psychiatry. 192(2). 135–143. 52 indexed citations
4.
McDonnell, David, Sebastian Sorsaburu, Eric J. Brunner, et al.. (2008). P.3.c.059 Post-injection delirium/sedation syndrome observed with olanzapine long-acting injection: review of the first 25 events. European Neuropsychopharmacology. 18. S437–S438. 5 indexed citations
5.
Bergstrom, Richard & E. Knoesel. (2007). Raman Spectroscopy of Carbon Nanotubes. Bulletin of the American Physical Society. 13 indexed citations
6.
Small, D. S., Corina Loghin, Ruth Lucas, et al.. (2005). Pharmacokinetic evaluation of combined duloxetine and fluvoxamine dosing in CYP2D6 poor metabolizers. Clinical Pharmacology & Therapeutics. 77(2). P37–P37. 7 indexed citations
7.
Kinon, Bruce J., et al.. (2002). Effectiveness of rapid initial dose escalation of oral olanzapine for acute agitation. European Neuropsychopharmacology. 12. 256–256. 2 indexed citations
8.
Tullus, Kjell, et al.. (1999). Efficacy and safety during long-term treatment of primary monosymptomatic nocturnal enuresis with desmopressin. Acta Paediatrica. 88(11). 1274–1278. 28 indexed citations
9.
Tullus, Kjell, et al.. (1999). Efficacy and safety during long‐term treatment f primary monosymptomatic nocturnal enuresis with desmopressin. Acta Paediatrica. 88(11). 1274–1278. 29 indexed citations
10.
11.
Lévy, Nicolas, Michael Blumenfield, Charles M. Beasley, et al.. (1996). Fluoxetine in depressed patients with renal failure and in depressed patients with normal kidney function. General Hospital Psychiatry. 18(1). 8–13. 54 indexed citations
12.
Ståhle, Elisabeth, et al.. (1994). Surgical treatment of left ventricular aneurysm — assessment of risk factors for early and late mortality. European Journal of Cardio-Thoracic Surgery. 8(2). 67–73. 11 indexed citations
13.
Lemberger, Louis, Richard Bergstrom, George R. Aronoff, Nazar Farid, & Robert L. Wolen. (1984). SPECIFIC SEROTONIN UPTAKE BLOCKERS. Clinical Neuropharmacology. 7. S172–S172. 1 indexed citations
14.
Nyberg, G., et al.. (1982). NEW DESIGN FOR CLINICAL TRIAL OF ANTIHYPERTENSIVE DRUGS APPLIED TO PINDOLOL, CLOPAMIDE, AND COMBINATIONS THEREOF. The Lancet. 319(8268). 355–358. 3 indexed citations
15.
Galloway, John A, Mary A. Root, Richard Bergstrom, et al.. (1982). Clinical Pharmacologic Studies with Human Insulin (recombinant DNA). Diabetes Care. 5(Supplement_2). 13–22. 32 indexed citations
16.
Bergstrom, Richard, et al.. (1953). Lead encephalopathy complicated by respiratory center depression.. PubMed. 9(11). 241–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cynthia J. Harris Breakdown of academic impact, for papers by B Astruc Breakdown of academic impact, for papers by Ersin Yariş Breakdown of academic impact, for papers by Robert M. Wallis Breakdown of academic impact, for papers by M. J. WATSON Breakdown of academic impact, for papers by Paul Williams Breakdown of academic impact, for papers by A. Cournot Breakdown of academic impact, for papers by Allen Mj Breakdown of academic impact, for papers by Kim Tang Breakdown of academic impact, for papers by Kevin F Foley
Rankless by CCL
2026